DDI Webinar- “Introduction to Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER”- February 23, 2016
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all healthcare professionals, pharmacy students, nurse practitioner students, physician assistants, and medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On February 23, 2016, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: "Introduction to Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER". The featured speaker was LCDR Monica Muñoz, PharmD, MS, BCPS, Safety Evaluator for FDA’s Division of Pharmacovigilance (DPV). The presentation gave an overview of pharmacovigilance: the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or other drug-related problems.
Presentation Information
- Introduction to Post-Marketing Drug Safety Surveillance
- Introduction to Post-Marketing Drug Safety Surveillance